---

---

tags : Genetown    exchanges : Nasdaq   

save search

---

Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024
Published: 2024-04-19 (Crawled : 21:00) - biospace.com/
NOVT | News | $149.28 -0.49% -0.5% 160K |

Electronic Technology

| -3.29% | O: -3.53% H: 1.09% C: 0.25%
conference growth

---

Gilead Sciences Publishes 2023 ESG Impact Report
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -0.25% | O: -0.04% H: 0.0% C: 0.0%
gilead report sciences impact esg

---

Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ALNY | $144.315 -0.58% -0.59% 700K |

Health Technology

| -1.57% | O: -1.17% H: 1.01% C: 0.11%
first conference financial results

---

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024Conference call scheduled for 4:30 p.m. Eastern Time
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ARDX | $6.5 0.93% 0.92% 5.6M |

Health Technology

| -3.71% | O: -2.97% H: 0.61% C: -1.38%
first report for financial results

---

Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
VRTX | News | $394.43 0.24% 0.24% 1.3M |

Health Technology

| 0.3% | O: 0.47% H: 0.0% C: 0.0%
vx-548

---

Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
ZLAB | $14.08 -0.99% -0.99% 470K |

Health Technology

| 2.55% | O: -1.24% H: 0.0% C: 0.0%
nuzyra pre-clinical pharmaceuticals global

---

Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K |

Health Technology

| -13.28% | O: -4.2% H: 0.0% C: 0.0%
presentation pharmaceuticals global

---

SaponiQx and InvivoGen Announce Agreement for SaponiQx to Supply Cultured Plant Cell QS-21 Adjuvant
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
AGEN | $5.3 6.64% 6.23% 1.5M |

Health Technology

| -15.71% | O: 0.0% H: 0.0% C: 0.0%
qs-21 cell for agreement

---

Vizgen Issued a New US Patent for Its MERFISH Technology
Published: 2024-04-16 (Crawled : 18:00) - biospace.com/
TXG | $27.92 -3.56% -3.69% 2M |

Health Technology

| -14.97% | O: -2.62% H: 0.57% C: -3.75%
patent for technology

---

VBI Vaccines Reports Full Year 2023 Financial Results
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
VBIV | $0.6396 1.57% 1.55% 160K |

Health Technology

| 8.62% | O: -3.45% H: 14.29% C: 10.71%
year financial results

---

Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BPMC | $86.87 -2.28% -2.34% 800K |

Health Technology

| -4.02% | O: 1.08% H: 1.19% C: 0.85%
conference for therapeutics

---

Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.64% | O: -100.0% H: NaN% C: Infinity%
VSTM | $9.86 -3.62% -3.75% 150K |

Health Technology

| -13.04% | O: -0.4% H: 4.84% C: 4.79%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -2.28% | O: 0.05% H: 0.0% C: 0.0%
medical therapeutics

---

Black Diamond Therapeutics Announces Changes to Board of Directors - April 11, 2024
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BDTX | $5.26 -0.76% -0.76% 390K |

Health Technology

| 2.04% | O: -3.01% H: 11.9% C: 11.4%
therapeutics

---

bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BLUE | $1.02 7.03% 6.11% 8.2M |

Health Technology

| -14.29% | O: 1.68% H: 1.65% C: -4.13%
nasdaq grants

---

Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
DCPH | $14.69 3.23% 3.13% 390K |

Health Technology

| -3.9% | O: -2.13% H: 5.02% C: 4.69%
pharmaceuticals

---

Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
MCRB | $0.5671 -2.93% -3.02% 3.7M |

Health Technology

| -24.02% | O: -2.31% H: 3.86% C: -1.47%
ser-155 for trial therapeutics

---

Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
SYRS | $4.54 -3.81% -3.96% 260K |

Health Technology

| -2.16% | O: 2.16% H: 23.21% C: 16.03%
fda treatment designation for aml

---

Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
OCUL | $5.22 -10.92% -12.26% 9.1M |

Health Technology

| -40.92% | O: -9.56% H: 2.44% C: 2.25%
nasdaq ocular global grants

---

Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)
Published: 2024-04-08 (Crawled : 22:00) - biospace.com/
BPTS | $0.29 -11.04% -12.41% 180K |

Manufacturing

| -15.7% | O: -3.31% H: 0.0% C: -4.69%
bio101 obesity study

---

Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
AMLX A | $1.88 -5.05% -5.32% 2.5M |

| -28.63% | O: 1.15% H: 7.92% C: 1.51%
amx0035 pharmaceuticals study

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---